PACB: Pacific Biosciences of California, Inc.
Performance
PACB +34.09%
Watchlist
Select an item
Summary
PACB at a glance
PACB returned +34.09% over the past year and -39.44% a year over five years. Its worst drop in that year was -58.43%, smaller than 14% of stocks on Redstone, and its Sharpe ratio of 0.73 beats 62% of stocks on Redstone. It pays no dividends.
Current Drawdown
-18.62%
Rolling Volatility
117.05%
Actions
Metrics
Risk Indicators
Alpha47.29%
Beta2.14x
Sharpe0.73
Sortino1.16
Omega1.13
Calmar0.58
Martin1.76
Profile
About PACB
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems.
- Sector
- Health Care
- Industry
- Laboratory Analytical Instruments
- Market cap
- $734M
- Listed
- Oct 2010
- Employees
- 485
- Headquarters
- Menlo Park, CA
- Website
- pacb.com
Comparisons